<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-81120" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Acanthamoeba Keratitis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Somani</surname>
            <given-names>Shaan N.</given-names>
          </name>
          <aff>Northwestern University Feinberg School of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ronquillo</surname>
            <given-names>Yasmyne</given-names>
          </name>
          <aff>Hoopes Vision Research Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Moshirfar</surname>
            <given-names>Majid</given-names>
          </name>
          <aff>University of Utah/John Moran Eye Center; Hoopes Vision/HDR Research Center; Utah Lions Eye Bank</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Shaan Somani declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Yasmyne Ronquillo declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Majid Moshirfar declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>23</day>
          <month>11</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-81120.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p><italic toggle="yes">Acanthamoeba</italic> keratitis (AK) is a rare but often misdiagnosed corneal infection, primarily affecting contact lens wearers and occasionally resulting from corneal trauma in non&#x02013;contact lens users. This infection is caused by the <italic toggle="yes">Acanthamoeba</italic> genus, a globally widespread unicellular protozoan parasite. Key risk factors include trauma, swimming in contaminated water, contact lens use in showers, lack of hygiene, and using contaminated lens solutions. Addressing the challenge of <italic toggle="yes">AK</italic>&#x000a0;involves educating patients about contact lens hygiene and behavior and enhancing contact lens disinfection systems targeting all <italic toggle="yes">Acanthamoeba</italic> strains. Regulatory considerations for over-the-counter lenses and developing effective diagnostic protocols are crucial. This educational activity emphasizes interprofessional collaboration among eye care professionals, educators, and regulatory bodies to advance patient care for this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Differentiate between Acanthamoeba keratitis and other forms of microbial keratitis, considering distinct etiologies and treatment approaches.</p></list-item><list-item><p>Implement standardized diagnostic protocols, incorporating advanced imaging techniques and laboratory tests, to confirm <italic toggle="yes">Acanthamoeba</italic> keratitis promptly and accurately.</p></list-item><list-item><p>Select appropriate antimicrobial agents, contact lens disinfection systems, and supportive therapies based on the specific <italic toggle="yes">Acanthamoeba</italic> strain and its susceptibility, ensuring optimal treatment outcomes.</p></list-item><list-item><p>Coordinate&#x000a0;interprofessional&#x000a0;care and follow-up to ensure comprehensive treatment and better patient outcomes in <italic toggle="yes">Acanthamoeba</italic> keratitis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=81120&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=81120">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-81120.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p><italic toggle="yes">Acanthamoeba</italic>&#x000a0;is a genus of protozoans widely&#x000a0;present in various habitats, including water, air, soil, and dust.<xref ref-type="bibr" rid="article-81120.r1">[1]</xref>&#x000a0;Initially identified in 1974, <italic toggle="yes">Acanthamoeba</italic> keratitis (AK) is a sight-threatening ocular infection&#x000a0;with a potentially&#x000a0;poor prognosis, primarily due to significant delays in diagnosis.<xref ref-type="bibr" rid="article-81120.r2">[2]</xref>&#x000a0;The etiology&#x000a0;of AK seems multifactorial,&#x000a0;with most cases&#x000a0;being associated with the use of&#x000a0;contact lenses and their cleaning solutions.<xref ref-type="bibr" rid="article-81120.r3">[3]</xref></p>
        <p>In the past&#x000a0;2 decades, there has been a&#x000a0;continuous increase&#x000a0;in contact lens users coupled with&#x000a0;inadequate&#x000a0;hygienic practices, elevated risk factors, and&#x000a0;improper handling methods, which&#x000a0;have led to increased risk of microbial keratitis, especially bacterial keratitis and AK.<xref ref-type="bibr" rid="article-81120.r4">[4]</xref>&#x000a0;AK,&#x000a0;a painful, sight-threatening&#x000a0;condition, profoundly impacts a patient's&#x000a0;quality of life.</p>
        <p>AK&#x000a0;closely&#x000a0;mimics other keratitis, often leading to&#x000a0;misdiagnosis and delayed treatment.&#x000a0;The condition&#x000a0;can&#x000a0;manifest with&#x000a0;a fluctuating course, and nonresolving cases&#x000a0;may require therapeutic keratoplasty to&#x000a0;preserve vision. AK is a rare corneal pathology with a prevalence of 1 to 9 cases per 100,000 individuals. The incidence of this condition in the&#x000a0;Western world&#x000a0;is&#x000a0;increasing due to its direct&#x000a0;association with contact lens&#x000a0;usage, which remains the primary risk factor for this condition.<xref ref-type="bibr" rid="article-81120.r5">[5]</xref></p>
        <p>Up to 93% of cases of AK are reported among contact lens wearers, emphasizing the crucial link between this eye infection and contact lens usage. Several risk factors contribute to the occurrence of&#x000a0;AK, including inadequate contact lens hygiene, overnight wear, prolonged use, lens use&#x000a0;during activities like swimming and showering, exposure to&#x000a0;contaminated water, trauma, and the use of contaminated contact lens solution.<xref ref-type="bibr" rid="article-81120.r6">[6]</xref>&#x000a0;Disposable contact lens users face an elevated risk, and orthokeratology has also been identified as a contributing factor,&#x000a0;with an annual incidence of 7.7 cases per 10,000 individuals.</p>
        <p>Acanthamoeba, a free-living protozoan, is&#x000a0;omnipresent&#x000a0;in freshwater and soil, existing in 2 distinct forms: the dormant cystic form and the motile trophozoite form. The cystic form, characterized by reduced metabolic&#x000a0;activity, exhibits&#x000a0;resistance&#x000a0;against&#x000a0;extreme conditions such as temperature variations, dry weather, pH fluctuations, and antiamoebic drugs. Despite advancements in diagnostic and treatment methods, cases of AK are still frequently missed or delayed, leading to detrimental effects on patient outcomes and quality of life. Delayed diagnosis can&#x000a0;result in&#x000a0;deeper corneal involvement, necessitating urgent keratoplasty to restore ocular anatomy and vision.<xref ref-type="bibr" rid="article-81120.r6">[6]</xref></p>
      </sec>
      <sec id="article-81120.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p><italic toggle="yes">Acanthamoeba</italic>&#x000a0;belongs to the phylum Amoebozoa, subphylum Lobosa, and order Centramoebida, as classified in biological taxonomy.<xref ref-type="bibr" rid="article-81120.r7">[7]</xref>&#x000a0;<italic toggle="yes">Acanthamoeba</italic>&#x000a0;species demonstrate remarkable adaptability, thriving in diverse environments such as&#x000a0;soil and aquatic settings, including ponds, swimming pools, hot tubs, and contact lens solutions. <italic toggle="yes">Acanthamoeba</italic> species are classified&#x000a0;through the 18s rDNA sequence analysis, categorizing them into distinct genotypes labeled T1 to T12.<xref ref-type="bibr" rid="article-81120.r8">[8]</xref> AK is most&#x000a0;commonly associated with specities within&#x000a0;the T4 genotype.<xref ref-type="bibr" rid="article-81120.r9">[9]</xref>&#x000a0;Among the species that cause AK,&#x000a0;<italic toggle="yes">Acanthamoeba castellani</italic> and <italic toggle="yes">Acanthamoeba polyphaga</italic> are the most frequently identified culprits.<xref ref-type="bibr" rid="article-81120.r10">[10]</xref></p>
        <p><italic toggle="yes">Acanthamoeba</italic> species&#x000a0;have 2 distinct&#x000a0;forms: an active trophozoite&#x000a0;and a dormant cyst. The trophozoite form feeds on bacteria, algae, and yeasts. Trophozoites&#x000a0;possess&#x000a0;slow locomotion abilities and can undergo asexual reproduction.<xref ref-type="bibr" rid="article-81120.r11">[11]</xref><xref ref-type="bibr" rid="article-81120.r12">[12]</xref>&#x000a0;In contrast, the cystic form&#x000a0;displays minimal metabolic activity and can endure harsh environmental conditions, including&#x000a0;drastic temperature or pH fluctuations, high doses of ultraviolet (UV) light, food scarcity, and desiccation.<xref ref-type="bibr" rid="article-81120.r13">[13]</xref></p>
      </sec>
      <sec id="article-81120.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The incidence of AK has been rising over recent decades.<xref ref-type="bibr" rid="article-81120.r14">[14]</xref>&#x000a0;Despite being traditionally perceived as a rare cause of keratitis, some studies have&#x000a0;indicated that <italic toggle="yes">Acanthamoeba</italic>&#x000a0;is responsible for&#x000a0;approximately 5% of cases of contact lens-associated keratitis.<xref ref-type="bibr" rid="article-81120.r15">[15]</xref>&#x000a0;AK predominantly affects&#x000a0;contact lens wearers, with reported rates ranging from 1 to 33 cases per million contact lens wearers annually.<xref ref-type="bibr" rid="article-81120.r1">[1]</xref>&#x000a0;The wide variation in incidence is attributed to regional differences in contact lens types, water contamination&#x000a0;in domestic and swimming pool environments, and&#x000a0;variances in the utilization&#x000a0;of diagnostic tests for AK.<xref ref-type="bibr" rid="article-81120.r16">[16]</xref>&#x000a0;</p>
        <p>Data from the Centers for Disease Control and Prevention&#x000a0;reveal that storing contact lenses in water or topping off solutions increases the risk of AK by 4.46 and 4.38 times, respectively.<xref ref-type="bibr" rid="article-81120.r17">[17]</xref>&#x000a0;Despite the common association of&#x000a0;poor lens hygiene with the development of AK,&#x000a0;this infection may still occur in individuals who properly clean their contact lenses. Most available multipurpose solutions are ineffective against <italic toggle="yes">Acanthamoeba,</italic><xref ref-type="bibr" rid="article-81120.r18">[18]</xref><xref ref-type="bibr" rid="article-81120.r19">[19]</xref>&#x000a0;with one study&#x000a0;demonstrating&#x000a0;the efficacy&#x000a0;of contact solutions containing hydrogen peroxide against<italic toggle="yes">&#x000a0;</italic>the organism.<xref ref-type="bibr" rid="article-81120.r20">[20]</xref>&#x000a0;Furthermore, AK&#x000a0;cases have&#x000a0;been reported in noncontact lens wearers,&#x000a0;particularly individuals with regular ocular exposure to dust, soil, or contaminated water sources.<xref ref-type="bibr" rid="article-81120.r21">[21]</xref></p>
        <p>AK&#x000a0;can&#x000a0;occur at any age but mainly affects individuals aged 40 to 60 and younger.<xref ref-type="bibr" rid="article-81120.r22">[22]</xref>&#x000a0;Individuals with compromised immune systems&#x000a0;are at a heightened risk of developing this condition.<xref ref-type="bibr" rid="article-81120.r23">[23]</xref>&#x000a0;There is no known sex predilection associated with AK.</p>
      </sec>
      <sec id="article-81120.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The initial&#x000a0;stages of ocular infection involve the pathogen&#x000a0;adhering to the corneal surface through mannose-binding protein and laminin-binding protein interactions.<xref ref-type="bibr" rid="article-81120.r24">[24]</xref><xref ref-type="bibr" rid="article-81120.r25">[25]</xref>&#x000a0;The adhesion process sets off&#x000a0;phagocytosis and prompts the release of various enzymes and toxins, including&#x000a0;neuraminidase, superoxide dismutase, protease, ecto-ATPase, phospholipases, glycosidases, and acanthaporin.<xref ref-type="bibr" rid="article-81120.r26">[26]</xref>&#x000a0;Consequently, corneal epithelial destruction and apoptosis occur,&#x000a0;facilitating&#x000a0;invasion&#x000a0;into the stroma.<xref ref-type="bibr" rid="article-81120.r27">[27]</xref><xref ref-type="bibr" rid="article-81120.r28">[28]</xref>&#x000a0;Once stromal degradation has occurred, the pathogen&#x000a0;can penetrate the cornea. <italic toggle="yes">Acanthamoeba</italic> proteases may also&#x000a0;damage the corneal nerves, leading to&#x000a0;severe pain and the characteristic slit lamp examination finding of radial keratoneuritis.<xref ref-type="bibr" rid="article-81120.r8">[8]</xref>&#x000a0;Notably, intraocular infection with <italic toggle="yes">Acanthamoeba</italic> is rare due to the intense response of polymorphonuclear leukocytes in the anterior chamber.<xref ref-type="bibr" rid="article-81120.r29">[29]</xref>&#x000a0;</p>
        <p>Several&#x000a0;factors indirectly contribute to the pathogenicity of <italic toggle="yes">Acanthamoeba</italic>, including&#x000a0;its widespread presence,&#x000a0;lack of distinct morphology, ability to tolerate a&#x000a0;broad range of temperatures and pH levels, and&#x000a0;capacity to reversibly differentiate into cysts or trophozoites.<xref ref-type="bibr" rid="article-81120.r26">[26]</xref>&#x000a0;These unique features enhance the adaptability of <italic toggle="yes">Acanthamoeba</italic> and contribute to its ability to cause ocular infections.</p>
        <p>Wearing contact lenses&#x000a0;induces microtrauma to the corneal epithelium and&#x000a0;upregulates glycoproteins. Soft contact lenses, in particular,&#x000a0;possess a more adhesive surface than hard lenses,&#x000a0;allowing&#x000a0;the <italic toggle="yes">Acanthamoeba </italic>trophozoite greater access to the cornea.<xref ref-type="bibr" rid="article-81120.r30">[30]</xref><xref ref-type="bibr" rid="article-81120.r31">[31]</xref></p>
      </sec>
      <sec id="article-81120.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>A&#x000a0;comprehensive patient history is crucial for all individuals displaying symptoms suggestive of ocular infection. Particular attention should&#x000a0;be given to&#x000a0;contact lens usage, recent corneal injuries, and dust, soil, or contaminated water exposure. AK&#x000a0;typically manifests&#x000a0;unilaterally, although it may rarely occur in both eyes.<xref ref-type="bibr" rid="article-81120.r30">[30]</xref>&#x000a0;A defining characteristic of AK, even in&#x000a0;its early stages, is severe pain disproportionate to the clinical findings believed to be triggered by the activity of trophozoite-derived proteases.<xref ref-type="bibr" rid="article-81120.r8">[8]</xref>&#x000a0;Patients&#x000a0;commonly&#x000a0;complain of reduced vision, eye redness, a foreign body sensation, photophobia, tearing, and discharge. Symptoms may&#x000a0;fluctuate in intensity, ranging from&#x000a0;mild to severe.<xref ref-type="bibr" rid="article-81120.r31">[31]</xref></p>
        <p>Alarmingly, 75% to 90% of patients with early AK are initially misdiagnosed,<xref ref-type="bibr" rid="article-81120.r11">[11]</xref>&#x000a0;underscoring the importance of considering AK&#x000a0;in patients&#x000a0;where symptoms persist for&#x000a0;several weeks without improvement&#x000a0;despite&#x000a0;strict adherence to&#x000a0;a daily regimen of topical antibiotics or antivirals. Clinicians should also be vigilant about the possibility of bacterial superinfection if symptoms worsen despite appropriate treatment initiation.</p>
        <p>A&#x000a0;thorough&#x000a0;ocular examination is essential for patients with suspected ocular infections. Early findings&#x000a0;during slit-lamp examination often reveal&#x000a0;epitheliopathy with punctuate keratopathy, epithelial or subepithelial infiltrates, pseudodendrites, and perineural infiltrates (see <bold>Image.&#x000a0;</bold><italic toggle="yes">Acanthamoeba</italic> Keratitis).<xref ref-type="bibr" rid="article-81120.r1">[1]</xref>&#x000a0;Perineural infiltrates, highly suggestive of AK,&#x000a0;have&#x000a0;been&#x000a0;observed in up to 63% of cases at&#x000a0;6 weeks,&#x000a0;although&#x000a0;they may regress&#x000a0;as the&#x000a0;disease progresses.<xref ref-type="bibr" rid="article-81120.r32">[32]</xref>&#x000a0;Late-stage AK is characterized by distinct features on slit-lamp examination, including a "ring-like" stromal infiltrate and radial keratoneuritis. Additionally, satellite lesions, ulceration, abscess formation, anterior uveitis with hypopyon, and epithelial defects are frequently seen.<xref ref-type="bibr" rid="article-81120.r31">[31]</xref>&#x000a0;Notably, the characteristic ring infiltrate is found in approximately 50% of patients with advanced disease.<xref ref-type="bibr" rid="article-81120.r26">[26]</xref>&#x000a0;Advanced AK can lead to stromal thinning and corneal perforation.<xref ref-type="bibr" rid="article-81120.r31">[31]</xref>&#x000a0;Since many&#x000a0;of these exam findings are nonspecific, clinicians must&#x000a0;maintain a high index of suspicion for AK, especially when the patient's history and other features strongly suggest&#x000a0;the possibility.</p>
        <p>
<bold>Early Presentation</bold>
</p>
        <p>
<bold>Epithelial</bold>
</p>
        <p>Epithelial involvement is the most common manifestation observed in 51.1% of patients. Other manifestations include dendritiform epitheliopathy, pseudodendrites, epithelial microcysts, epithelial microcysts, epithelial infiltrates, and epithelial ridges.<xref ref-type="bibr" rid="article-81120.r33">[33]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Subepithelial</bold>
<list list-type="bullet"><list-item><p>Punctate keratopathy</p></list-item><list-item><p>Subepithelial infiltrates<xref ref-type="bibr" rid="article-81120.r33">[33]</xref></p></list-item></list>
</p>
          </list-item>
        </list>
        <p>
<bold>Late Presentation</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Stromal involvement</bold>
<list list-type="bullet"><list-item><p>Radial perineuritis is present in 63% of cases</p></list-item><list-item><p>Ring infiltrates are present in 20% of cases</p></list-item><list-item><p>Nummular infiltrates</p></list-item><list-item><p>Diffuse infiltration is seen in 64%</p></list-item><list-item><p>Corneal melt and perforation</p></list-item><list-item><p>Hypopyon&#x000a0;<xref ref-type="bibr" rid="article-81120.r5">[5]</xref></p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Extracorneal manifestations</bold>
<list list-type="bullet"><list-item><p>Limbitis</p></list-item><list-item><p>Scleritis</p></list-item><list-item><p>Sterile uveitis</p></list-item><list-item><p>Dacryoadenitis<xref ref-type="bibr" rid="article-81120.r11">[11]</xref></p></list-item></list>
</p>
          </list-item>
        </list>
        <p>
<bold>Acanthamoeba Keratitis Misdiagnosis</bold>
</p>
        <p>Overall, 75% to 90% of AK cases are misdiagnosed. Among these, 47.6% are&#x000a0;erroneously identified&#x000a0;as herpetic keratitis, 25.2%&#x000a0;as mycotic keratitis, and 3.9% as bacterial keratitis.<xref ref-type="bibr" rid="article-81120.r34">[34]</xref></p>
      </sec>
      <sec id="article-81120.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The&#x000a0;plate culture technique has traditionally been considered the gold standard for&#x000a0;<italic toggle="yes">Acanthamoeba</italic> detection. However, recent advancements have highlighted the growing&#x000a0;importance of&#x000a0;polymerase chain reaction (PCR), in vivo confocal microscopy (IVCM), and staining methods in diagnosis.</p>
        <p>Corneal scraping or biopsy is required to obtain a sample for culture. The corneal scrapings are smeared on calcofluor white (CFW) or Gram stain. The cysts&#x000a0;present as double-walled structures, with the inner wall&#x000a0;appearing hexagonal.&#x000a0;Distinguishing&#x000a0;trophozoites&#x000a0;from inflammatory cells can be challenging.&#x000a0;</p>
        <p>A&#x000a0;key advantage of staining techniques is their ability to provide immediate diagnosis. Gram stain exhibits a sensitivity of 60% and a specificity of 99.9% for cyst detection. In KOH mounts, sensitivity is 91.4%, and specificity is 99.9%.&#x000a0;CFW mount&#x000a0;displays cysts as light green structures, with a sensitivity of 79.6% and specificity of 100%. Combined KOH and CFW sensitivity is 87.1%. Since <italic toggle="yes">Acanthamoeba</italic>&#x000a0;trophozoites feed on bacteria, cultures develop on 1.5% nonnutrient agar plates covered by&#x000a0;<italic toggle="yes">E. Coli</italic>.<xref ref-type="bibr" rid="article-81120.r35">[35]</xref>&#x000a0;However, the rate of positive culture results for <italic toggle="yes">Acanthamoeba&#x000a0;</italic>in AK settings is generally low,&#x000a0;ranging&#x000a0;from 40% to 70%.<xref ref-type="bibr" rid="article-81120.r36">[36]</xref>&#x000a0;Samples require daily observation for up to a&#x000a0;week before a negative result can be confidently declared.<xref ref-type="bibr" rid="article-81120.r26">[26]</xref>&#x000a0;</p>
        <p>Scraping, corneal biopsy, and contact lens solution culture on Nicolle Novy-McNeal (N.N.N.) medium&#x000a0;yield&#x000a0;a sensitivity of 70%,&#x000a0;with&#x000a0;results&#x000a0;becoming readable&#x000a0;after 3 weeks. Immunohistological staining&#x000a0;using monoclonal antibodies has demonstrated utility, although this technique is time-consuming and&#x000a0;demands the expertise of a skilled microbiologist for interpretation.<xref ref-type="bibr" rid="article-81120.r37">[37]</xref></p>
        <p>PCR has&#x000a0;shown significant&#x000a0;advancements in detecting&#x000a0;<italic toggle="yes">Acanthamoeba</italic>&#x000a0;over the past decade. The 18s rRNA region is&#x000a0;the most commonly employed target in clinical samples, with new primer sets demonstrating a sensitivity of 100% and specificity of 96%.<xref ref-type="bibr" rid="article-81120.r37">[37]</xref>&#x000a0;PCR&#x000a0;offers notable&#x000a0;advantages, being widely accessible, rapid, and requiring less labor. There is&#x000a0;growing&#x000a0;speculation&#x000a0;that PCR may&#x000a0;emerge as the new gold standard for diagnosing AK.<xref ref-type="bibr" rid="article-81120.r37">[37]</xref> PCR is an adjunct to culture and smear methods, providing reports&#x000a0;within&#x000a0;an hour. Additionally, PCR can detect nonviable&#x000a0;<italic toggle="yes">Acanthamoeba</italic>, enhancing its utility for confirming&#x000a0;positive results.</p>
        <p>A corneal biopsy is&#x000a0;recommended in&#x000a0;cases of smear and culture-negative AK with&#x000a0;extensive stromal&#x000a0;involvement. The reported sensitivity is 56%.&#x000a0;When subjected to periodic acid Schiff staining, the corneal biopsy reveals the presence of&#x000a0;<italic toggle="yes">Acanthamoeba</italic> cysts, confirming the infection.</p>
        <p>Some authors&#x000a0;recommend&#x000a0;that clinicians&#x000a0;collect the most recent pair of contact lenses and lens cases for culture&#x000a0;and PCR.<xref ref-type="bibr" rid="article-81120.r1">[1]</xref>&#x000a0;However, nearly all contact lens cases,&#x000a0;including those belonging to healthy contact lens wearers,&#x000a0;yield&#x000a0;positive results for&#x000a0;<italic toggle="yes">Acanthamoeba</italic>&#x000a0;on PCR. Consequently, the absence of&#x000a0;<italic toggle="yes">Acanthamoeba</italic>&#x000a0;in a culture of a contact lens case strongly indicates&#x000a0;a diagnosis other than AK.<xref ref-type="bibr" rid="article-81120.r26">[26]</xref>&#x000a0;The definitive diagnosis of AK relies on either culture with histology or PCR to identify&#x000a0;<italic toggle="yes">Acanthamoeba</italic>&#x000a0;deoxyribonucleic acid (DNA).</p>
        <p>IVCM is an invaluable noninvasive tool that&#x000a0;enables real-time examination of individual corneal cells. IVCM reliably detects cysts appearing as well-defined, round, double-walled, hyper-reflective bodies. One study reported a pooled sensitivity and specificity of&#x000a0;rates of 85.3% and 100%, respectively, for IVCM. Additionally, IVCM&#x000a0;can monitor disease progression and assess treatment response.<xref ref-type="bibr" rid="article-81120.r36">[36]</xref>&#x000a0;Despite its effectiveness, IVCM is&#x000a0;costly and may not always be readily available.<xref ref-type="bibr" rid="article-81120.r38">[38]</xref></p>
        <p>Another study reported confocal microscopy exhibited a sensitivity of 90% and a specificity of 91%.&#x000a0;This technique is rapid, noninvasive, and has the capability to identify only double-walled cysts. Alternatively, cytology smears&#x000a0;provide&#x000a0;a viable method&#x000a0;for detecting <italic toggle="yes">Acanthamoeba</italic>&#x000a0;cysts&#x000a0;in corneal scrapings or biopsied tissue. Cytology smears&#x000a0;offer the advantage of being fast, easily performed, and&#x000a0;widely available in most facilities. Unlike culture, cytology smears do not require live organisms or intact DNA as&#x000a0;needed&#x000a0;for&#x000a0;PCR.<xref ref-type="bibr" rid="article-81120.r38">[38]</xref>&#x000a0;</p>
        <p>Several stains, including lactophenol-cotton blue, Giemsa, CFW, and acridine orange, are&#x000a0;commonly used due to their&#x000a0;speed and&#x000a0;accuracy. However, VFW and Giemsa require a fluorescent microscope and may lead to false positives due to cellular debris staining.<xref ref-type="bibr" rid="article-81120.r26">[26]</xref><xref ref-type="bibr" rid="article-81120.r39">[39]</xref>&#x000a0;The silver stain becomes necessary when clinicians&#x000a0;require&#x000a0;specific cyst morphology. Some evidence suggests that hematoxylin and eosin (H&#x00026;E) staining is more sensitive and specific than other stains, especially CFW and Giemsa.<xref ref-type="bibr" rid="article-81120.r39">[39]</xref><xref ref-type="bibr" rid="article-81120.r40">[40]</xref>&#x000a0;Notably,&#x000a0;there has been at least&#x000a0;1 study&#x000a0;where H&#x00026;E staining&#x000a0;enabled&#x000a0;the diagnosis of AK even without a positive culture result.<xref ref-type="bibr" rid="article-81120.r41">[41]</xref></p>
        <p>Several innovative diagnostic&#x000a0;methods have been employed&#x000a0;for diagnosing AK. Loop-mediated isothermal amplification (LAMP) has&#x000a0;shown&#x000a0;a high sensitivity and specificity, comparable to PCR, in&#x000a0;diagnosing&#x000a0;AK.&#x000a0;Unlike PCR, LAMP amplifies the target sequence at a constant temperature of 60 &#x000b0;C to 65 &#x000b0;C, eliminating the need for an expensive thermal cycler. LAMP could be an alternative to PCR for future AK diagnoses due to its simplicity and affordability.<xref ref-type="bibr" rid="article-81120.r35">[35]</xref>&#x000a0;Additionally, researchers have explored noninvasive imaging techniques, including Heidelberg retina tomography II (HRT II) and nuclear magnetic resonance (NMR) spectroscopy.<xref ref-type="bibr" rid="article-81120.r35">[35]</xref>&#x000a0;However, further studies are necessary to&#x000a0;establish their sensitivity and specificity</p>
      </sec>
      <sec id="article-81120.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p><italic toggle="yes">Acanthamoeba</italic>&#x000a0;trophozoites display&#x000a0;sensitivity to various medications, including antibiotics, antiseptics, antifungals, and antiprotozoals (see <bold>Table.&#x000a0;</bold>Available&#x000a0;Drug&#x000a0;Therapies for <italic toggle="yes">Acanthamoeba</italic> Keratitis). However, the cystic form of&#x000a0;<italic toggle="yes">Acanthamoeba</italic>&#x000a0;is resistant to most of these treatments,&#x000a0;leading to&#x000a0;prolonged infections.<xref ref-type="bibr" rid="article-81120.r1">[1]</xref>&#x000a0;</p>
        <p>Diamidines and biguanides are&#x000a0;2 classes of antiemetics often utilized as first-line therapy for&#x000a0;AK&#x000a0;due to their proven cysticidal effects. When used individually or in combination, these topical antiemetics&#x000a0;exhibit efficacy ranging from 35% to 86%.<xref ref-type="bibr" rid="article-81120.r32">[32]</xref>&#x000a0;Medical and surgical options may be&#x000a0;considered in cases of treatment-resistant AK.</p>
        <table-wrap id="article-81120.table0" position="float" orientation="portrait">
          <caption>
            <title>Table 1.&#x000a0;Available&#x000a0;Drug&#x000a0;Therapies for Acanthamoeba Keratitis</title>
          </caption>
          <table style="width: 700px;" border="1" cellspacing="1" cellpadding="5">
            <tbody>
              <tr>
                <td style="width: 122.219px;" rowspan="1" colspan="1">
<p><bold>Class</bold></p>
</td>
                <td style="width: 149.781px;" rowspan="1" colspan="1">
<p><bold>Mechanism</bold></p>
</td>
                <td style="width: 252px;" rowspan="1" colspan="1">
<p><bold>Examples</bold></p>
</td>
              </tr>
              <tr>
                <td style="width: 122.219px;" rowspan="1" colspan="1">
<p>Biguanides</p>
</td>
                <td style="width: 149.781px;" rowspan="1" colspan="1">
<p>Inhibit membrane function</p>
</td>
                <td style="width: 252px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Polyhexamethylene biguanide (PHMB)</p></list-item><list-item><p>Chlorhexidine</p></list-item></list>
</td>
              </tr>
              <tr>
                <td style="width: 122.219px;" rowspan="1" colspan="1">
<p>Aromatic diamidines</p>
</td>
                <td style="width: 149.781px;" rowspan="1" colspan="1">
<p>Inhibit DNA synthesis</p>
</td>
                <td style="width: 252px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Propamidine (brolene)</p></list-item><list-item><p>Hexamidine</p></list-item></list>
</td>
              </tr>
              <tr>
                <td style="width: 122.219px;" rowspan="1" colspan="1">
<p>Aminoglycosides</p>
</td>
                <td style="width: 149.781px;" rowspan="1" colspan="1">
<p>Inhibit protein synthesis</p>
</td>
                <td style="width: 252px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Neomycin</p></list-item><list-item><p>Paromomycin</p></list-item></list>
</td>
              </tr>
              <tr>
                <td style="width: 122.219px;" rowspan="1" colspan="1">
<p>Imidazoles</p>
</td>
                <td style="width: 149.781px;" rowspan="1" colspan="1">
<p>Destabilize the cell wall</p>
</td>
                <td style="width: 252px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Clotrimazole</p></list-item><list-item><p>Ketoconazole</p></list-item></list>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <table-wrap id="article-81120.table1" position="float" orientation="portrait">
          <caption>
            <title>Table 2. Drug&#x000a0;Treatment Guidelines for Acanthamoeba Keratitis&#x000a0;</title>
          </caption>
          <table style="border-color: black; width: 700px;" border="1" cellspacing="1" cellpadding="2">
            <tbody>
              <tr style="height: 35px;">
                <td style="width: 207.469px; height: 35px;" rowspan="1" colspan="1">
<p><bold>First Line Therapy</bold></p>
</td>
                <td style="width: 64.5312px; height: 35px;" rowspan="1" colspan="1">
<p><bold>Concentration </bold></p>
</td>
                <td style="width: 257px; height: 35px;" rowspan="1" colspan="1">
<p><bold>Frequency</bold></p>
</td>
              </tr>
              <tr style="height: 2.5px;">
                <td style="width: 207.469px; height: 2.5px;" rowspan="1" colspan="1">
<p>Chlorhexidine</p>
<p>&#x000a0; &#x000a0;+</p>
<p>Brolene</p>
</td>
                <td style="width: 64.5312px; height: 2.5px;" rowspan="1" colspan="1">
<p>0.02%</p>
<p>0.1%</p>
</td>
                <td style="width: 257px; height: 2.5px; text-align: left;" rowspan="1" colspan="1">
<p>Every hour for 2 to 3 days, then every 1 hour while awake for 3 days, then tapered to 4 times daily. Titrated based on toxicity and response</p>
</td>
              </tr>
              <tr style="height: 2px;">
                <td style="width: 207.469px; height: 2px;" rowspan="1" colspan="1">
<p><bold>Second Line Therapy</bold></p>
</td>
                <td style="width: 64.5312px; height: 2px;" rowspan="1" colspan="1">
</td>
                <td style="width: 257px; height: 2px; text-align: left;" rowspan="1" colspan="1">
</td>
              </tr>
              <tr style="height: 2px;">
                <td style="width: 207.469px; height: 2px;" rowspan="1" colspan="1">
<p>PHMB</p>
</td>
                <td style="width: 64.5312px; height: 2px;" rowspan="1" colspan="1">
<p>0.02% to 0.06%</p>
</td>
                <td style="width: 257px; height: 2px; text-align: left;" rowspan="1" colspan="1">
<p>Every hour for 2 to 3 days, then every 1 hour while awake for 3 days, then tapered to 4 times daily</p>
</td>
              </tr>
              <tr style="height: 2px;">
                <td style="width: 207.469px; height: 2px;" rowspan="1" colspan="1">
<p>Hexamidine</p>
</td>
                <td style="width: 64.5312px; height: 2px;" rowspan="1" colspan="1">
<p>0.1%</p>
</td>
                <td style="width: 257px; height: 2px; text-align: left;" rowspan="1" colspan="1">
</td>
              </tr>
              <tr style="height: 2px;">
                <td style="width: 207.469px; height: 2px;" rowspan="1" colspan="1">
<p>Pentamidine</p>
</td>
                <td style="width: 64.5312px; height: 2px;" rowspan="1" colspan="1">
<p>0.1%</p>
</td>
                <td style="width: 257px; height: 2px; text-align: left;" rowspan="1" colspan="1">
</td>
              </tr>
              <tr style="height: 2px;">
                <td style="width: 207.469px; height: 2px;" rowspan="1" colspan="1">
<p><bold>Third Line Therapy</bold></p>
</td>
                <td style="width: 64.5312px; height: 2px;" rowspan="1" colspan="1">
</td>
                <td style="width: 257px; height: 2px; text-align: left;" rowspan="1" colspan="1">
</td>
              </tr>
              <tr style="height: 2px;">
                <td style="width: 207.469px; height: 2px;" rowspan="1" colspan="1">
<p>Imidazoles</p>
</td>
                <td style="width: 64.5312px; height: 2px;" rowspan="1" colspan="1">
<p>1%</p>
</td>
                <td style="width: 257px; height: 2px; text-align: left;" rowspan="1" colspan="1">
<p>Use hourly during the initial period</p>
</td>
              </tr>
              <tr style="height: 2px;">
                <td style="width: 207.469px; height: 2px;" rowspan="1" colspan="1">
<p>Neomycin</p>
</td>
                <td style="width: 64.5312px; height: 2px;" rowspan="1" colspan="1">
<p>10 mg/mL</p>
</td>
                <td style="width: 257px; height: 2px; text-align: left;" rowspan="1" colspan="1">
<p>Titrated based on&#x000a0;toxicity and&#x000a0;response</p>
</td>
              </tr>
              <tr style="height: 2px;">
                <td style="width: 207.469px; height: 2px;" rowspan="1" colspan="1">
<p><bold>Adjunctive Therapy</bold></p>
</td>
                <td style="width: 64.5312px; height: 2px;" rowspan="1" colspan="1">
</td>
                <td style="width: 257px; height: 2px; text-align: left;" rowspan="1" colspan="1">
</td>
              </tr>
              <tr style="height: 2px;">
                <td style="width: 207.469px; height: 2px;" rowspan="1" colspan="1">
<p>NSAIDs</p>
</td>
                <td style="width: 64.5312px; height: 2px;" rowspan="1" colspan="1">
<p>Topical or oral</p>
</td>
                <td style="width: 257px; height: 2px; text-align: left;" rowspan="1" colspan="1">
<p>&#x000a0;2 to 4 times daily as needed</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>Diamidines exert their therapeutic effect by&#x000a0;modifying the structure and permeability of the cell membrane,&#x000a0;resulting in the denaturation of cytoplasmic contents (see&#x000a0;<bold>Table.&#x000a0;</bold>Drug Treatment Guidelines for <italic toggle="yes">Acanthamoeba</italic>&#x000a0;Keratitis)&#x000a0;Propamidine-isethionate, hexamidine-diisethionate, and dibromopropamidine are diamidines used for the treatment of acanthamoeba keratitis at 0.1% concentration.<xref ref-type="bibr" rid="article-81120.r1">[1]</xref>&#x000a0;While diamidines are generally well-tolerated, prolonged therapy at the therapeutic level can lead to ocular surface toxicity.<xref ref-type="bibr" rid="article-81120.r42">[42]</xref></p>
        <p>Biguanides function similarly by&#x000a0;causing&#x000a0;modifications&#x000a0;in cytoplasmic membranes, leading to the loss of cellular components and the inhibition of enzymes&#x000a0;crucial&#x000a0;for cell respiration. Among biguanides, PHMB and chlorhexidine are the&#x000a0;2 most widely used for&#x000a0;AK treatment. PHMB is&#x000a0;typically initiated&#x000a0;at a concentration of 0.02% but can be escalated to 0.06% for AK cases that&#x000a0;are unresponsive or severe at the initial presentation. Similarly, chlorhexidine is usually&#x000a0;started at a concentration of 0.02% but&#x000a0;may be increased to 0.2% if necessary.<xref ref-type="bibr" rid="article-81120.r1">[1]</xref></p>
        <p>
<bold>PHMB in Comparison with Chlorhexidine</bold>
</p>
        <p>In a randomized controlled trial conducted in the United Kingdom&#x000a0;involving 56 eyes,&#x000a0;the study&#x000a0;concluded that the chlorhexidine group exhibited 86% resolution of infection, control of inflammation, pain relief, and photosensitivity&#x000a0;compared to 78% in the PHMB group. Regarding visual acuity resolution, 71%&#x000a0;showed&#x000a0;improvement in visual acuity in the chlorhexidine group compared to 57% in the PHMB group.</p>
        <p>Most modern treatment&#x000a0;protocols advocate&#x000a0;for&#x000a0;initiating&#x000a0;combination therapy&#x000a0;involving a biguanide and a diamidine. However, recent research&#x000a0;indicates&#x000a0;that PHMB 0.08% monotherapy is as effective as the combination of PHMB 0.02% and propamidine 0.1%.<xref ref-type="bibr" rid="article-81120.r43">[43]</xref>&#x000a0;</p>
        <p>Early intensive treatment is more effective since cysts have not yet fully matured.<xref ref-type="bibr" rid="article-81120.r32">[32]</xref>&#x000a0;Medications are&#x000a0;administered&#x000a0;hourly, both day and night, for the&#x000a0;initial 48 hours,&#x000a0;after which the frequency is&#x000a0;reduced to hourly during the daytime for several days to weeks.<xref ref-type="bibr" rid="article-81120.r1">[1]</xref>&#x000a0;As the infection subsides, the frequency may further&#x000a0;decrease to&#x000a0;4 times daily, a regimen maintained for&#x000a0;6 months to a year.<xref ref-type="bibr" rid="article-81120.r11">[11]</xref><xref ref-type="bibr" rid="article-81120.r44">[44]</xref>&#x000a0;The&#x000a0;objective of this prolonged therapy is to ensure the complete eradication of&#x000a0;<italic toggle="yes">Acanthamoeba</italic>&#x000a0;cysts. Premature treatment discontinuation could allow any remaining dormant cysts to differentiate into trophozoites. Clinicians should tailor treatment&#x000a0;plans for each case&#x000a0;to minimize risks of epithelial toxicity.<xref ref-type="bibr" rid="article-81120.r1">[1]</xref></p>
        <p>Neomycin was&#x000a0;previously a primary treatment for AK&#x000a0;because&#x000a0;of its anti-trophozoite properties, although it&#x000a0;does not&#x000a0;seem to&#x000a0;reach cysticidal levels in vitro.<xref ref-type="bibr" rid="article-81120.r32">[32]</xref>&#x000a0;Nevertheless, neomycin serves a role in&#x000a0;preventing bacterial superinfection and&#x000a0;reducing bacterial food for trophozoites. Some physicians include topical neomycin 1%&#x000a0;5 times daily as part of an initial triple therapy. This inclusion may have an additive effect when&#x000a0;combined with biguanides and diamidines, making it a strategic choice in the treatment regimen.<xref ref-type="bibr" rid="article-81120.r11">[11]</xref><xref ref-type="bibr" rid="article-81120.r45">[45]</xref></p>
        <p>Approximately 39% of patients with&#x000a0;AK&#x000a0;do not respond to initial therapy. Individuals with more severe clinical&#x000a0;presentations or a history of corticosteroid use before diagnosis&#x000a0;face a higher&#x000a0;likelihood of treatment failure.<xref ref-type="bibr" rid="article-81120.r14">[14]</xref>&#x000a0;Numerous other medications&#x000a0;can act&#x000a0;as&#x000a0;adjunct treatments&#x000a0;alongside biguanides and diamidines. Miltefosine, recently approved by the Food and Drugs Administration (FDA), is an antiamebic agent that has shown promise as an adjuvant treatment for treatment-resistant AK.<xref ref-type="bibr" rid="article-81120.r46">[46]</xref><xref ref-type="bibr" rid="article-81120.r47">[47]</xref>&#x000a0;However, the literature surrounding its use is still evolving, necessitating further studies to clarify its role and establish the optimal timing, dosage, and route of administration.</p>
        <p>The therapeutic&#x000a0;effectiveness of antifungals appears to be restricted in AK. Among all antifungals, only newer-generation azoles like voriconazole and posaconazole&#x000a0;seem to&#x000a0;attain cysticidal levels in vitro.<xref ref-type="bibr" rid="article-81120.r48">[48]</xref>&#x000a0;However, in vivo,&#x000a0;the sustainability of treatment response might be questionable.<xref ref-type="bibr" rid="article-81120.r49">[49]</xref>&#x000a0;Natamycin demonstrated better&#x000a0;cysticidal effects than PHMB in vitro,&#x000a0;although data on its use in animal models is&#x000a0;currently&#x000a0;unavailable.<xref ref-type="bibr" rid="article-81120.r50">[50]</xref></p>
        <p>Epithelial debridement&#x000a0;can enhance&#x000a0;the penetration of topical medications.<xref ref-type="bibr" rid="article-81120.r1">[1]</xref>&#x000a0;If AK&#x000a0;is unresponsive to conservative topical treatment, various surgical options&#x000a0;are available, including penetrating keratoplasty (PK), corneal cryoplasty, amniotic membrane transplantation, and riboflavin-UVA cross-linking.<xref ref-type="bibr" rid="article-81120.r51">[51]</xref><xref ref-type="bibr" rid="article-81120.r52">[52]</xref><xref ref-type="bibr" rid="article-81120.r53">[53]</xref>&#x000a0;Notably, PK was the first-line therapy for AK before the advent of biguanides and diamidines. PK is typically&#x000a0;reserved for patients with significant cataracts,&#x000a0;severe corneal abscesses, corneal perforation, or therapy-resistant ulceration with peripheral neovascularization.<xref ref-type="bibr" rid="article-81120.r32">[32]</xref>&#x000a0;Following PK, topical treatment should continue for up to&#x000a0;1 year.<xref ref-type="bibr" rid="article-81120.r11">[11]</xref>&#x000a0; Therapeutic PK (TPK) has successfully treated medically unresponsive cases of AK, although multiple grafts may be necessary, and the prognosis remains guarded.</p>
        <p>Indications for&#x000a0;PK include cornea scleral involvement, progressive keratitis, resistance to medical therapy&#x000a0;persisting over weeks to months in a disease lasting less than 5 months, nonhealing epithelial defect, and peripheral neovascularization. Deep anterior lamellar keratoplasty (DALK) offers a more promising prognosis in eradicating the infection and promoting graft survival. In a study conducted by Sarnicola et al., DALK&#x000a0;was performed in 11 cases of AK&#x000a0;during therapy, with no episodes of recurrence&#x000a0;or failure reported.&#x000a0;</p>
        <p>Management options for cases resistant to treatment, such as nonhealing epithelial defects, include corneal cryotherapy, amniotic membrane transplantation, PK, and DALK. Cryotherapy is&#x000a0;used as an adjunct to PK, applied before&#x000a0;recipient trephination. The cold cryoprobe is applied 2 to 3 times (freeze-thaw-freeze), although caution is necessary to prevent affecting the limbal stem cell configuration.<xref ref-type="bibr" rid="article-81120.r54">[54]</xref></p>
        <p>Several promising novel therapeutic approaches are under exploration. A case series involving 4 patients treated with photorefractive surgery showed excellent visual outcomes with no disease recurrence.<xref ref-type="bibr" rid="article-81120.r55">[55]</xref>&#x000a0;Other case reports have&#x000a0;suggested a role for collagen cross-linking in the management of AK.<xref ref-type="bibr" rid="article-81120.r56">[56]</xref>&#x000a0;</p>
        <p>Tissue studies have&#x000a0;highlighted the&#x000a0;cysticidal effect of&#x000a0;3 antidiabetic agents (glimepiride, vildagliptin, and repaglinide) against <italic toggle="yes">Acanthamoeba</italic>
<italic toggle="yes">castellanii</italic>, particularly when combined with silver nanoparticles.<xref ref-type="bibr" rid="article-81120.r57">[57]</xref>&#x000a0;Moreover, the combination of titanium dioxide and UV-A demonstrated a synergistic cysticidal effect against&#x000a0;<italic toggle="yes">Acanthamoeba&#x000a0;</italic>species when compounded with chlorhexidine in vitro.<xref ref-type="bibr" rid="article-81120.r58">[58]</xref>&#x000a0;</p>
        <p>Clinical trials in animal models are necessary to assess the efficacy and safety of these novel therapies. Future research avenues might include&#x000a0;exploring&#x000a0;genetic markers and delving into stem cell research; however,&#x000a0;these endeavors&#x000a0;would require a better understanding of the disease at a molecular level.</p>
        <p>Developing extracorneal manifestations like scleritis or limbitis&#x000a0;signify a&#x000a0;more serious&#x000a0;condition&#x000a0;and warrants treatment with anti-inflammatory medications. Most cases of extracorneal inflammation are manageable with oral flurbiprofen at 50 to 100 mg, taken&#x000a0;2&#x000a0;to&#x000a0;3 times daily.<xref ref-type="bibr" rid="article-81120.r32">[32]</xref>&#x000a0;Scleritis or limbitis unresponsive to NSAIDs may benefit from high-dose systemic steroids (prednisolone 1 mg/kg/day), and other systemic immunosuppressive agents such as cyclosporine (3.0 to 7.5 mg/kg/day) may be necessary.<xref ref-type="bibr" rid="article-81120.r32">[32]</xref>&#x000a0;These medications may&#x000a0;need to be continued&#x000a0;for several months to control inflammation and eradicate the pathogen.</p>
        <p>The use of topical corticosteroids in AK remains controversial and is discouraged by many physicians.&#x000a0;While typically unnecessary in the early stages,&#x000a0;topical steroids may be&#x000a0;required&#x000a0;in significant anterior segment inflammation cases.<xref ref-type="bibr" rid="article-81120.r1">[1]</xref>&#x000a0;Steroids should be prescribed judiciously due to the risk of promoting encystment and increasing trophozoite numbers.<xref ref-type="bibr" rid="article-81120.r11">[11]</xref>&#x000a0;Clinicians&#x000a0;must&#x000a0;never prescribe steroids without concurrent administration of antiemetic agents, and antiamoebic therapy should continue for several weeks after discontinuing steroids.<xref ref-type="bibr" rid="article-81120.r1">[1]</xref></p>
        <p>Although topical steroids&#x000a0;reduce inflammation,&#x000a0;they can&#x000a0;transform cysts into trophozoites, worsening&#x000a0;the infection. Additionally, steroids mask clinical signs.</p>
        <p>Topical steroids are indicated in cases with a progressive increase in deep corneal vascularization or when the patient develops inflammatory complications of AK, such as scleritis, anterior chamber inflammation, persistent chronic keratitis, and severe pain out of proportion to the exam. Corticosteroid therapy is&#x000a0;considered after completing&#x000a0;at least 2 weeks of biguanide treatment. Antiamoebic therapy&#x000a0;must persist&#x000a0;even after steroid discontinuation.&#x000a0;During follow-up visits, it is&#x000a0;crucial to&#x000a0;monitor for the&#x000a0;infection recurrence. Biguanides are continued&#x000a0;at low doses&#x000a0;4 times daily after&#x000a0;stopping&#x000a0;steroid therapy.</p>
        <p>
<bold>Role of Corneal Collagen Cross-linking</bold>
</p>
        <p>In vivo and in vitro studies have failed to demonstrate&#x000a0;a cysticidal or amoebicidal effect. In cases with stromal infiltrates, UV light penetration&#x000a0;into the corneal stroma is diminished. The&#x000a0;effectiveness of corneal collagen cross-linking with riboflavin (C3R) in AK is still debated.</p>
      </sec>
      <sec id="article-81120.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>One study&#x000a0;revealed clinicians initially misdiagnosed nearly half of all&#x000a0;AK&#x000a0;cases as herpes simplex keratitis (HSK).<xref ref-type="bibr" rid="article-81120.r59">[59]</xref>&#x000a0;The pseudodendrites observed in early AK may resemble the epithelial dendrites seen in HSK; however, AK pseudodendrites lack a knot-like widening at the terminal ends of the erosion,&#x000a0;a characteristic feature of&#x000a0;herpetic dendrites.<xref ref-type="bibr" rid="article-81120.r11">[11]</xref>&#x000a0;AK&#x000a0;can&#x000a0;be&#x000a0;differentiated from HSK by the presence of perineural and ring infiltrates, whereas HSK is more likely to involve the endothelium.<xref ref-type="bibr" rid="article-81120.r26">[26]</xref>&#x000a0;AK is polymicrobial or coinfected with herpes simplex virus in 10% to 23% of cases.<xref ref-type="bibr" rid="article-81120.r1">[1]</xref></p>
        <p>AK&#x000a0;can&#x000a0;occasionally be mistaken for&#x000a0;bacterial or mycotic keratitis. Ring infiltrates,&#x000a0;typically associated with AK, may also&#x000a0;appear in&#x000a0;bacterial and mycotic keratitis.<xref ref-type="bibr" rid="article-81120.r11">[11]</xref>&#x000a0;However, in the absence of a superinfection, AK is more likely to present with multifocal, transparent stromal infiltrate rather than monofocal, thicker infiltrates seen in bacterial and mycotic infections.<xref ref-type="bibr" rid="article-81120.r11">[11]</xref>&#x000a0;Moreover, bacterial keratitis is more&#x000a0;prone to extend beyond the cornea and involve the anterior chamber.<xref ref-type="bibr" rid="article-81120.r26">[26]</xref></p>
        <p>The multifocal stromal infiltrates&#x000a0;observed in AK&#x000a0;may resemble the satellite infiltrates of fungal keratitis. However, AK&#x000a0;can be&#x000a0;differentiated from fungal keratitis&#x000a0;during slit-lamp examination by the presence of translucent epithelial defects, perineural stromal infiltrates, and ring infiltrates. Fungal keratitis is more&#x000a0;prone to extend beyond the cornea.<xref ref-type="bibr" rid="article-81120.r26">[26]</xref>&#x000a0;Additionally, the culture of fungal keratitis would typically yield a positive result on Sabouraud agar.</p>
        <p>Unlike patients&#x000a0;with uncomplicated bacterial or fungal keratitis, patients with AK&#x000a0;tend&#x000a0;to be younger and often experience a&#x000a0;more extended duration of symptoms at the initial presentation.<xref ref-type="bibr" rid="article-81120.r60">[60]</xref>&#x000a0;However,&#x000a0;AK&#x000a0;has been&#x000a0;observed to coexist frequently with bacterial and fungal keratitis.<xref ref-type="bibr" rid="article-81120.r61">[61]</xref>&#x000a0;Consequently, the degree to which patients&#x02019; demographic factors should&#x000a0;be considered&#x000a0;in&#x000a0;formulating a differential diagnosis remains unclear.</p>
        <p>The differential diagnosis for AK includes the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Contact lens-associated keratitis</p>
          </list-item>
          <list-item>
            <p>Conjunctivitis&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Dry eye</p>
          </list-item>
          <list-item>
            <p>HSK: presents with dendritic or geographic ulcers</p>
          </list-item>
          <list-item>
            <p>Recurrent corneal erosion</p>
          </list-item>
          <list-item>
            <p>Staphylococcal marginal keratitis</p>
          </list-item>
          <list-item>
            <p>Fungal keratitis: has thicker infiltrates and is typically monofocal</p>
          </list-item>
          <list-item>
            <p>Bacterial keratitis</p>
          </list-item>
        </list>
        <p>The absence of the terminal bulb is a distinguishing feature in AK,&#x000a0;where stromal infiltrates manifest as&#x000a0;transparent, dot-like, and multifocal. This unique pattern of stromal infiltrates in AK often aids clinicians in accurately diagnosing the condition and differentiating it from other forms of keratitis. Early detection is crucial for prompt and effective management.</p>
      </sec>
      <sec id="article-81120.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The&#x000a0;prognosis of AK is heavily influenced by the disease's&#x000a0;severity at presentation and the timeliness of effective therapy initiation.<xref ref-type="bibr" rid="article-81120.r62">[62]</xref>&#x000a0;Delays in diagnosis often result in corneal scarring, leading to a poor prognosis. However,&#x000a0;patients who begin treatment within&#x000a0;3 weeks of symptom onset generally&#x000a0;experience favorable&#x000a0;visual outcomes.<xref ref-type="bibr" rid="article-81120.r32">[32]</xref>&#x000a0;</p>
        <p>A worse prognosis is associated with the presence of cataracts or involvement&#x000a0;beyond the cornea.<xref ref-type="bibr" rid="article-81120.r1">[1]</xref>&#x000a0;Elective PK may be&#x000a0;considered&#x000a0;for vision improvement,&#x000a0;although some experts recommend&#x000a0;performing it only after the infection has resolved and treatment has been discontinued for 3 months.<xref ref-type="bibr" rid="article-81120.r1">[1]</xref>&#x000a0;There&#x000a0;is no reported variation in the prognosis of AK based on the specific&#x000a0;<italic toggle="yes">Acanthamoeba</italic> genus involved.</p>
      </sec>
      <sec id="article-81120.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Common complications of AK include glaucoma, iris atrophy, broad-based anterior synechiae, cataracts, and persistent endothelial defects.&#x000a0;In rare cases, patients may develop complications such as&#x000a0;scleritis, sterile anterior uveitis, chorioretinitis, and retinal vasculitis.<xref ref-type="bibr" rid="article-81120.r11">[11]</xref>&#x000a0;</p>
        <p>Scleritis, observed in approximately 10% of AK&#x000a0;cases, is thought to result from an inflammatory response of unknown etiology rather than a direct invasion of <italic toggle="yes">Acanthamoeba</italic>.<xref ref-type="bibr" rid="article-81120.r32">[32]</xref>&#x000a0;Management of extracorneal inflammation involves appropriate anti-inflammatory treatments.</p>
      </sec>
      <sec id="article-81120.s12" sec-type="Postoperative and Rehabilitation Care">
        <title>Postoperative and Rehabilitation Care</title>
        <p>Postoperative management of AK aligns with protocols for other microbial keratitis. Following TPK, the&#x000a0;patient is initially treated with anti-<italic toggle="yes">Acanthamoeba</italic>&#x000a0;drugs such as PHMB and chlorhexidine, administered 6 to 8 times daily,&#x000a0;with adjustments based on&#x000a0;the clinical response. In cases with recurrence, the anti-A<italic toggle="yes">canthamoeba</italic> therapy can be&#x000a0;intensified&#x000a0;to use every 1 to 2 hours, continuing for at least 2 to 3 weeks.<xref ref-type="bibr" rid="article-81120.r26">[26]</xref></p>
        <p>Steroids can be&#x000a0;introduced&#x000a0;3 weeks later, under the cover of anti-<italic toggle="yes">Acanthamoeba</italic> drugs, initially administered 3 times daily.&#x000a0;If&#x000a0;no recurrence is observed, the steroid regimen can be adjusted accordingly:</p>
        <list list-type="bullet">
          <list-item>
            <p>Increase to 4 times daily for 3 months, then 3 times daily for 3 months, then 2 times daily for 3 months, then 1 time daily until graft survival</p>
          </list-item>
        </list>
        <p>Additionally, adjuvant&#x000a0;medications&#x000a0;like cycloplegics and antiglaucoma&#x000a0;drugs should be incorporated to&#x000a0;protect the eye. Examples of medications to consider are as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Cycloplegics
<list list-type="bullet"><list-item><p>Atropine</p></list-item><list-item><p>Homatropine</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Antiglaucoma
<list list-type="bullet"><list-item><p>Timolol&#x000a0;</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>Regular and timely follow-up appointments are essential for the patient's ongoing care and recovery.<xref ref-type="bibr" rid="article-81120.r63">[63]</xref>&#x000a0;Close monitoring allows for prompt detection of potential complications or recurrence, ensuring that appropriate interventions can be implemented swiftly to optimize the patient's visual outcomes and overall eye health.</p>
      </sec>
      <sec id="article-81120.s13" sec-type="Consultations">
        <title>Consultations</title>
        <p>Patients suspected of having AK should be referred to a cornea specialist for accurate diagnosis and specialized management. Patients who develop cataracts as a complication should be directed to a cataract surgeon&#x000a0;for appropriate&#x000a0;surgical intervention. Similarly, for cases involving glaucoma,&#x000a0;referral to a specialized glaucoma clinic is essential for comprehensive and targeted management of the condition.<xref ref-type="bibr" rid="article-81120.r11">[11]</xref></p>
      </sec>
      <sec id="article-81120.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients, particularly contact lens wearers, should receive comprehensive education on preventing AK.&#x000a0;Education should include avoiding overnight wear of contact lenses, refraining from using homemade saline solutions, and not wearing lenses while swimming or showering. Utilizing daily disposable lenses instead of reusable ones might lower the risk of AK,&#x000a0;although this is still unproven.<xref ref-type="bibr" rid="article-81120.r64">[64]</xref>&#x000a0;</p>
        <p>Individuals regularly exposed to dirt, soil,&#x000a0;or contaminated water should wear suitable protective eyewear. Furthermore, enhancing clinician's understanding of Acanthamoeba's pathogenesis could significantly benefit patient care.<xref ref-type="bibr" rid="article-81120.r32">[32]</xref></p>
      </sec>
      <sec id="article-81120.s15" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Key facts to&#x000a0;keep in mind about AK are as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>AK is a rare and challenging condition to diagnose and treat.&#x000a0;Clinicians should maintain a high suspicion for AK when encountering cases of keratitis unresponsive to standard first-line treatments. Being vigilant in considering this possibility is crucial for accurate diagnosis and timely intervention.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Most&#x000a0;cases involving AK develop in contact lens wearers. While inadequate lens hygiene is often cited, it is worth noting that many multipurpose solutions are ineffective against <italic toggle="yes">Acanthamoeba</italic>.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>On slit-lamp examination, AK is characterized by ring-shaped infiltrate and radial keratoneuritis. Notably, ring-shaped infiltrates are typically observed in&#x000a0;the advanced stages and found in&#x000a0;only 50% of patients.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Biguanides and diamidines are the first-line treatments for AK. The&#x000a0;utilization of topical corticosteroids is controversial and discouraged by&#x000a0;most&#x000a0;physicians.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-81120.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Patients&#x000a0;displaying symptoms suggestive of ocular infection&#x000a0;are likely to consult&#x000a0;their primary care physicians or visit the emergency department. Consequently, these&#x000a0;healthcare practitioners must&#x000a0;know about AK and its distinctive presentation. Direct referral to a cornea specialist, as opposed to other ophthalmologists, significantly reduces the likelihood of treatment failure, with 3.2 times lower odds&#x000a0;associated with this approach.<xref ref-type="bibr" rid="article-81120.r14">[14]</xref>&#x000a0;</p>
        <p>Effective communication&#x000a0;among the pathologist, cornea specialist, and microbiologist is crucial&#x000a0;for&#x000a0;implementing isolation techniques&#x000a0;essential in identifying&#x000a0;<italic toggle="yes">Acanthamoeba</italic>. Primary care clinicians, including nurses and pharmacists, educate&#x000a0;patients on proper contact lens hygiene. Patients should&#x000a0;be advised to remove contact lenses during water-related activities, use fresh&#x000a0;storage solutions, and practice thorough handwashing before touching their contacts. Immediate consultation with an eye specialist is strongly recommended if a patient wearing contact lenses develops&#x000a0;eye redness, pain, or photophobia.</p>
        <p>Pharmacists are integral in coordinating with treating clinicians to ensure appropriate agent selection, dosing, and&#x000a0;monitoring for drug interactions. Ophthalmology-specialized nurses&#x000a0;can verify compliance, monitor therapeutic progress, and&#x000a0;remain vigilant for adverse events. To facilitate optimal outcomes in managing AK, pharmacists and nurses&#x000a0;should maintain&#x000a0;an open communication channel&#x000a0;with prescribers, enabling them to address any issues promptly. Effective interprofessional collaboration is fundamental for achieving optimal results in the management of AK.</p>
      </sec>
      <sec id="article-81120.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=81120&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=81120">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/eye-health/acanthamoeba-keratitis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=81120">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/81120/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=81120">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-81120.s18">
        <fig id="article-81120.image.f1" position="float" orientation="portrait">
          <caption>
            <p><italic toggle="yes">Acanthamoeba</italic> Keratitis Image courtesy S Bhimji MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="acanthamoeba__keratitis" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-81120.s19">
        <title>References</title>
        <ref id="article-81120.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maycock</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Jayaswal</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Update on Acanthamoeba Keratitis: Diagnosis, Treatment, and Outcomes.</article-title>
            <source>Cornea</source>
            <year>2016</year>
            <month>May</month>
            <volume>35</volume>
            <issue>5</issue>
            <fpage>713</fpage>
            <page-range>713-20</page-range>
            <pub-id pub-id-type="pmid">26989955</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Naginton</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Watson</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Playfair</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>McGill</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Steele</surname>
                <given-names>AD</given-names>
              </name>
            </person-group>
            <article-title>Amoebic infection of the eye.</article-title>
            <source>Lancet</source>
            <year>1974</year>
            <month>Dec</month>
            <day>28</day>
            <volume>2</volume>
            <issue>7896</issue>
            <fpage>1537</fpage>
            <page-range>1537-40</page-range>
            <pub-id pub-id-type="pmid">4140981</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Verani</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Lorick</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Yoder</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Beach</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Braden</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Conover</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>McConnell</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Visvesvara</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Roy</surname>
                <given-names>SL</given-names>
              </name>
              <collab>AcanthamoebaKeratitis Investigation Team</collab>
            </person-group>
            <article-title>National outbreak of Acanthamoeba keratitis associated with use of a contact lens solution, United States.</article-title>
            <source>Emerg Infect Dis</source>
            <year>2009</year>
            <month>Aug</month>
            <volume>15</volume>
            <issue>8</issue>
            <fpage>1236</fpage>
            <page-range>1236-42</page-range>
            <pub-id pub-id-type="pmid">19751585</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stellwagen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>MacGregor</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kung</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Konstantopoulos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hossain</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Personal hygiene risk factors for contact lens-related microbial keratitis.</article-title>
            <source>BMJ Open Ophthalmol</source>
            <year>2020</year>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>e000476</fpage>
            <pub-id pub-id-type="pmid">32953996</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fanselow</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sirajuddin</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Yin</surname>
                <given-names>XT</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>AJW</given-names>
              </name>
              <name>
                <surname>Stuart</surname>
                <given-names>PM</given-names>
              </name>
            </person-group>
            <article-title><italic>Acanthamoeba</italic> Keratitis, Pathology, Diagnosis and Treatment.</article-title>
            <source>Pathogens</source>
            <year>2021</year>
            <month>Mar</month>
            <day>10</day>
            <volume>10</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">33801905</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Radford</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Minassian</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Dart</surname>
                <given-names>JK</given-names>
              </name>
            </person-group>
            <article-title>Acanthamoeba keratitis in England and Wales: incidence, outcome, and risk factors.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2002</year>
            <month>May</month>
            <volume>86</volume>
            <issue>5</issue>
            <fpage>536</fpage>
            <page-range>536-42</page-range>
            <pub-id pub-id-type="pmid">11973250</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smirnov</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Chao</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Nassonova</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Cavalier-Smith</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>A revised classification of naked lobose amoebae (Amoebozoa: lobosa).</article-title>
            <source>Protist</source>
            <year>2011</year>
            <month>Oct</month>
            <volume>162</volume>
            <issue>4</issue>
            <fpage>545</fpage>
            <page-range>545-70</page-range>
            <pub-id pub-id-type="pmid">21798804</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clarke</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Niederkorn</surname>
                <given-names>JY</given-names>
              </name>
            </person-group>
            <article-title>The pathophysiology of Acanthamoeba keratitis.</article-title>
            <source>Trends Parasitol</source>
            <year>2006</year>
            <month>Apr</month>
            <volume>22</volume>
            <issue>4</issue>
            <fpage>175</fpage>
            <page-range>175-80</page-range>
            <pub-id pub-id-type="pmid">16500148</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kong</surname>
                <given-names>HH</given-names>
              </name>
            </person-group>
            <article-title>Molecular phylogeny of acanthamoeba.</article-title>
            <source>Korean J Parasitol</source>
            <year>2009</year>
            <month>Oct</month>
            <volume>47 Suppl</volume>
            <issue>Suppl</issue>
            <fpage>S21</fpage>
            <page-range>S21-8</page-range>
            <pub-id pub-id-type="pmid">19885332</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Booton</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Visvesvara</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Byers</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Kelly</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Fuerst</surname>
                <given-names>PA</given-names>
              </name>
            </person-group>
            <article-title>Identification and distribution of Acanthamoeba species genotypes associated with nonkeratitis infections.</article-title>
            <source>J Clin Microbiol</source>
            <year>2005</year>
            <month>Apr</month>
            <volume>43</volume>
            <issue>4</issue>
            <fpage>1689</fpage>
            <page-range>1689-93</page-range>
            <pub-id pub-id-type="pmid">15814986</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Szentm&#x000e1;ry</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Daas</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Laurik</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Lepper</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Milioti</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Seitz</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Acanthamoeba keratitis - Clinical signs, differential diagnosis and treatment.</article-title>
            <source>J Curr Ophthalmol</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>31</volume>
            <issue>1</issue>
            <fpage>16</fpage>
            <page-range>16-23</page-range>
            <pub-id pub-id-type="pmid">30899841</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Siddiqui</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>NA</given-names>
              </name>
            </person-group>
            <article-title>Biology and pathogenesis of Acanthamoeba.</article-title>
            <source>Parasit Vectors</source>
            <year>2012</year>
            <month>Jan</month>
            <day>10</day>
            <volume>5</volume>
            <fpage>6</fpage>
            <pub-id pub-id-type="pmid">22229971</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Biddick</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Rogers</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>TJ</given-names>
              </name>
            </person-group>
            <article-title>Viability of pathogenic and nonpathogenic free-living amoebae in long-term storage at a range of temperatures.</article-title>
            <source>Appl Environ Microbiol</source>
            <year>1984</year>
            <month>Oct</month>
            <volume>48</volume>
            <issue>4</issue>
            <fpage>859</fpage>
            <page-range>859-60</page-range>
            <pub-id pub-id-type="pmid">6508294</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Randag</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>van Rooij</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>van Goor</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Verkerk</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wisse</surname>
                <given-names>RPL</given-names>
              </name>
              <name>
                <surname>Saelens</surname>
                <given-names>IEY</given-names>
              </name>
              <name>
                <surname>Stoutenbeek</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>van Dooren</surname>
                <given-names>BTH</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>YYY</given-names>
              </name>
              <name>
                <surname>Eggink</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>The rising incidence of Acanthamoeba keratitis: A 7-year nationwide survey and clinical assessment of risk factors and functional outcomes.</article-title>
            <source>PLoS One</source>
            <year>2019</year>
            <volume>14</volume>
            <issue>9</issue>
            <fpage>e0222092</fpage>
            <pub-id pub-id-type="pmid">31491000</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Acharya</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Lietman</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Margolis</surname>
                <given-names>TP</given-names>
              </name>
            </person-group>
            <article-title>Parasites on the rise: a new epidemic of Acanthamoeba keratitis.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2007</year>
            <month>Aug</month>
            <volume>144</volume>
            <issue>2</issue>
            <fpage>292</fpage>
            <page-range>292-3</page-range>
            <pub-id pub-id-type="pmid">17659960</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ibrahim</surname>
                <given-names>YW</given-names>
              </name>
              <name>
                <surname>Boase</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Cree</surname>
                <given-names>IA</given-names>
              </name>
            </person-group>
            <article-title>Factors affecting the epidemiology of Acanthamoeba keratitis.</article-title>
            <source>Ophthalmic Epidemiol</source>
            <year>2007</year>
            <season>Mar-Apr</season>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>53</fpage>
            <page-range>53-60</page-range>
            <pub-id pub-id-type="pmid">17464851</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ju&#x000e1;rez</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>T&#x000e1;rtara</surname>
                <given-names>LI</given-names>
              </name>
              <name>
                <surname>Cid</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Real</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Berm&#x000fa;dez</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Rajal</surname>
                <given-names>VB</given-names>
              </name>
              <name>
                <surname>Palma</surname>
                <given-names>SD</given-names>
              </name>
            </person-group>
            <article-title>Acanthamoeba in the eye, can the parasite hide even more? Latest developments on the disease.</article-title>
            <source>Cont Lens Anterior Eye</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>41</volume>
            <issue>3</issue>
            <fpage>245</fpage>
            <page-range>245-251</page-range>
            <pub-id pub-id-type="pmid">29273391</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zanetti</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fiori</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Pinna</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Usai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Carta</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fadda</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Susceptibility of Acanthamoeba castellanii to contact lens disinfecting solutions.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>1995</year>
            <month>Jul</month>
            <volume>39</volume>
            <issue>7</issue>
            <fpage>1596</fpage>
            <page-range>1596-8</page-range>
            <pub-id pub-id-type="pmid">7492111</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shoff</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Joslin</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Tu</surname>
                <given-names>EY</given-names>
              </name>
              <name>
                <surname>Kubatko</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Fuerst</surname>
                <given-names>PA</given-names>
              </name>
            </person-group>
            <article-title>Efficacy of contact lens systems against recent clinical and tap water Acanthamoeba isolates.</article-title>
            <source>Cornea</source>
            <year>2008</year>
            <month>Jul</month>
            <volume>27</volume>
            <issue>6</issue>
            <fpage>713</fpage>
            <page-range>713-9</page-range>
            <pub-id pub-id-type="pmid">18580265</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Johnston</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Sriram</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Qvarnstrom</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Roy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Verani</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yoder</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lorick</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Beach</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Visvesvara</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Resistance of Acanthamoeba cysts to disinfection in multiple contact lens solutions.</article-title>
            <source>J Clin Microbiol</source>
            <year>2009</year>
            <month>Jul</month>
            <volume>47</volume>
            <issue>7</issue>
            <fpage>2040</fpage>
            <page-range>2040-5</page-range>
            <pub-id pub-id-type="pmid">19403771</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garg</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kalra</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Joseph</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Non-contact lens related <italic>Acanthamoeba</italic> keratitis.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>65</volume>
            <issue>11</issue>
            <fpage>1079</fpage>
            <page-range>1079-1086</page-range>
            <pub-id pub-id-type="pmid">29133630</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jiang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Acanthamoeba keratitis: clinical characteristics and management.</article-title>
            <source>Ocul Surf</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>164</fpage>
            <page-range>164-8</page-range>
            <pub-id pub-id-type="pmid">25881999</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bunsuwansakul</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mahboob</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hounkong</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Laohaprapanon</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chitapornpan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jawjit</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yasiri</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Barusrux</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bunluepuech</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sawangjaroen</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Salibay</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Kaewjai</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pereira</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Nissapatorn</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Acanthamoeba in Southeast Asia - Overview and Challenges.</article-title>
            <source>Korean J Parasitol</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>57</volume>
            <issue>4</issue>
            <fpage>341</fpage>
            <page-range>341-357</page-range>
            <pub-id pub-id-type="pmid">31533401</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Matin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shin</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yoo</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Yuan</surname>
                <given-names>XZ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Jung</surname>
                <given-names>SY</given-names>
              </name>
            </person-group>
            <article-title>Functional roles of mannose-binding protein in the adhesion, cytotoxicity and phagocytosis of Acanthamoeba castellanii.</article-title>
            <source>Exp Parasitol</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>132</volume>
            <issue>2</issue>
            <fpage>287</fpage>
            <page-range>287-92</page-range>
            <pub-id pub-id-type="pmid">22940016</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hong</surname>
                <given-names>YC</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Kong</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Jeong</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>DI</given-names>
              </name>
            </person-group>
            <article-title>Molecular cloning and characterization of a cDNA encoding a laminin-binding protein (AhLBP) from Acanthamoeba healyi.</article-title>
            <source>Exp Parasitol</source>
            <year>2004</year>
            <season>Mar-Apr</season>
            <volume>106</volume>
            <issue>3-4</issue>
            <fpage>95</fpage>
            <page-range>95-102</page-range>
            <pub-id pub-id-type="pmid">15172216</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lorenzo-Morales</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Walochnik</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment.</article-title>
            <source>Parasite</source>
            <year>2015</year>
            <volume>22</volume>
            <fpage>10</fpage>
            <pub-id pub-id-type="pmid">25687209</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hadas</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mazur</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Proteolytic enzymes of pathogenic and non-pathogenic strains of Acanthamoeba spp.</article-title>
            <source>Trop Med Parasitol</source>
            <year>1993</year>
            <month>Sep</month>
            <volume>44</volume>
            <issue>3</issue>
            <fpage>197</fpage>
            <page-range>197-200</page-range>
            <pub-id pub-id-type="pmid">8256097</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cao</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Jefferson</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Panjwani</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Role of carbohydrate-mediated adherence in cytopathogenic mechanisms of Acanthamoeba.</article-title>
            <source>J Biol Chem</source>
            <year>1998</year>
            <month>Jun</month>
            <day>19</day>
            <volume>273</volume>
            <issue>25</issue>
            <fpage>15838</fpage>
            <page-range>15838-45</page-range>
            <pub-id pub-id-type="pmid">9624184</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Illingworth</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Cook</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Karabatsas</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Easty</surname>
                <given-names>DL</given-names>
              </name>
            </person-group>
            <article-title>Acanthamoeba keratitis: risk factors and outcome.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1995</year>
            <month>Dec</month>
            <volume>79</volume>
            <issue>12</issue>
            <fpage>1078</fpage>
            <page-range>1078-82</page-range>
            <pub-id pub-id-type="pmid">8562539</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wilhelmus</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Matoba</surname>
                <given-names>AY</given-names>
              </name>
              <name>
                <surname>Hamill</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Pflugfelder</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Weikert</surname>
                <given-names>MP</given-names>
              </name>
            </person-group>
            <article-title>Bilateral acanthamoeba keratitis.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2008</year>
            <month>Feb</month>
            <volume>145</volume>
            <issue>2</issue>
            <fpage>193</fpage>
            <page-range>193-197</page-range>
            <pub-id pub-id-type="pmid">18222188</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alkharashi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lindsley</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Law</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Sikder</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Medical interventions for acanthamoeba keratitis.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2015</year>
            <month>Feb</month>
            <day>24</day>
            <volume>2015</volume>
            <issue>2</issue>
            <fpage>CD010792</fpage>
            <pub-id pub-id-type="pmid">25710134</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dart</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Saw</surname>
                <given-names>VP</given-names>
              </name>
              <name>
                <surname>Kilvington</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Acanthamoeba keratitis: diagnosis and treatment update 2009.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2009</year>
            <month>Oct</month>
            <volume>148</volume>
            <issue>4</issue>
            <fpage>487</fpage>
            <page-range>487-499.e2</page-range>
            <pub-id pub-id-type="pmid">19660733</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Holland</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Alul</surname>
                <given-names>IH</given-names>
              </name>
              <name>
                <surname>Meisler</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Epstein</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Rotkis</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Nathenson</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Liesegang</surname>
                <given-names>TJ</given-names>
              </name>
            </person-group>
            <article-title>Subepithelial infiltrates in Acanthamoeba keratitis.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1991</year>
            <month>Oct</month>
            <day>15</day>
            <volume>112</volume>
            <issue>4</issue>
            <fpage>414</fpage>
            <page-range>414-8</page-range>
            <pub-id pub-id-type="pmid">1928244</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Srikumaran</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Zafar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Salehi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Woreta</surname>
                <given-names>FA</given-names>
              </name>
            </person-group>
            <article-title>Case series: Delayed diagnoses of Acanthamoeba keratitis.</article-title>
            <source>Am J Ophthalmol Case Rep</source>
            <year>2020</year>
            <month>Sep</month>
            <volume>19</volume>
            <fpage>100778</fpage>
            <pub-id pub-id-type="pmid">32566802</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Feng</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Current advances in diagnostic methods of Acanthamoeba keratitis.</article-title>
            <source>Chin Med J (Engl)</source>
            <year>2014</year>
            <volume>127</volume>
            <issue>17</issue>
            <fpage>3165</fpage>
            <page-range>3165-70</page-range>
            <pub-id pub-id-type="pmid">25189964</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>YE</given-names>
              </name>
              <name>
                <surname>Tepelus</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Vickers</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Baghdasaryan</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gui</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Irvine</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Sadda</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hsu</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>OL</given-names>
              </name>
            </person-group>
            <article-title>Role of in vivo confocal microscopy in the diagnosis of infectious keratitis.</article-title>
            <source>Int Ophthalmol</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>39</volume>
            <issue>12</issue>
            <fpage>2865</fpage>
            <page-range>2865-2874</page-range>
            <pub-id pub-id-type="pmid">31209694</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Karsenti</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lau</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Purssell</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chong-Kit</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cunanan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gasgas</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tian</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ralevski</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Boggild</surname>
                <given-names>AK</given-names>
              </name>
            </person-group>
            <article-title>Development and validation of a real-time PCR assay for the detection of clinical acanthamoebae.</article-title>
            <source>BMC Res Notes</source>
            <year>2017</year>
            <month>Jul</month>
            <day>28</day>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>355</fpage>
            <pub-id pub-id-type="pmid">28754142</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patel</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Schaefer</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Jaber</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Paterson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Gonzalez-Fernandez</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>The Value of Cytology Smears for Acanthamoeba Keratitis.</article-title>
            <source>Case Rep Ophthalmol Med</source>
            <year>2016</year>
            <volume>2016</volume>
            <fpage>4148968</fpage>
            <pub-id pub-id-type="pmid">27403362</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>El-Sayed</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Hikal</surname>
                <given-names>WM</given-names>
              </name>
            </person-group>
            <article-title>Several staining techniques to enhance the visibility of Acanthamoeba cysts.</article-title>
            <source>Parasitol Res</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>114</volume>
            <issue>3</issue>
            <fpage>823</fpage>
            <page-range>823-30</page-range>
            <pub-id pub-id-type="pmid">25346196</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grossniklaus</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Waring</surname>
                <given-names>GO</given-names>
              </name>
              <name>
                <surname>Akor</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Castellano-Sanchez</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Bennett</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of hematoxylin and eosin and special stains for the detection of acanthamoeba keratitis in penetrating keratoplasties.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2003</year>
            <month>Sep</month>
            <volume>136</volume>
            <issue>3</issue>
            <fpage>520</fpage>
            <page-range>520-6</page-range>
            <pub-id pub-id-type="pmid">12967807</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mathers</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Sutphin</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Folberg</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Meier</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Wenzel</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Elgin</surname>
                <given-names>RG</given-names>
              </name>
            </person-group>
            <article-title>Outbreak of keratitis presumed to be caused by Acanthamoeba.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1996</year>
            <month>Feb</month>
            <volume>121</volume>
            <issue>2</issue>
            <fpage>129</fpage>
            <page-range>129-42</page-range>
            <pub-id pub-id-type="pmid">8623882</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dorlo</surname>
                <given-names>TP</given-names>
              </name>
              <name>
                <surname>Balasegaram</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Beijnen</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>de Vries</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis.</article-title>
            <source>J Antimicrob Chemother</source>
            <year>2012</year>
            <month>Nov</month>
            <volume>67</volume>
            <issue>11</issue>
            <fpage>2576</fpage>
            <page-range>2576-97</page-range>
            <pub-id pub-id-type="pmid">22833634</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Papa</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Rama</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Radford</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Minassian</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Dart</surname>
                <given-names>JKG</given-names>
              </name>
            </person-group>
            <article-title><italic>Acanthamoeba</italic> keratitis therapy: time to cure and visual outcome analysis for different antiamoebic therapies in 227 cases.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2020</year>
            <month>Apr</month>
            <volume>104</volume>
            <issue>4</issue>
            <fpage>575</fpage>
            <page-range>575-581</page-range>
            <pub-id pub-id-type="pmid">31401556</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Radford</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Lehmann</surname>
                <given-names>OJ</given-names>
              </name>
              <name>
                <surname>Dart</surname>
                <given-names>JK</given-names>
              </name>
            </person-group>
            <article-title>Acanthamoeba keratitis: multicentre survey in England 1992-6. National Acanthamoeba Keratitis Study Group.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1998</year>
            <month>Dec</month>
            <volume>82</volume>
            <issue>12</issue>
            <fpage>1387</fpage>
            <page-range>1387-92</page-range>
            <pub-id pub-id-type="pmid">9930269</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marchenko</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Kasparova</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>[Treatment of Acanthamoeba keratitis].</article-title>
            <source>Vestn Oftalmol</source>
            <year>2016</year>
            <volume>132</volume>
            <issue>5</issue>
            <fpage>110</fpage>
            <page-range>110-116</page-range>
            <pub-id pub-id-type="pmid">28635735</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tavassoli</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Buckle</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tole</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Chiodini</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Darcy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>The use of miltefosine in the management of refractory Acanthamoeba keratitis.</article-title>
            <source>Cont Lens Anterior Eye</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>41</volume>
            <issue>4</issue>
            <fpage>400</fpage>
            <page-range>400-402</page-range>
            <pub-id pub-id-type="pmid">29580956</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dewan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ming</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Holland</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Yeung</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Iovieno</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Oral Miltefosine as Adjunctive Treatment for Recalcitrant Acanthamoeba Keratitis.</article-title>
            <source>Cornea</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>38</volume>
            <issue>7</issue>
            <fpage>914</fpage>
            <page-range>914-917</page-range>
            <pub-id pub-id-type="pmid">31170106</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iovieno</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ledee</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Alfonso</surname>
                <given-names>EC</given-names>
              </name>
            </person-group>
            <article-title>Cysticidal activity of antifungals against different genotypes of Acanthamoeba.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>58</volume>
            <issue>9</issue>
            <fpage>5626</fpage>
            <page-range>5626-8</page-range>
            <pub-id pub-id-type="pmid">25001304</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tu</surname>
                <given-names>EY</given-names>
              </name>
              <name>
                <surname>Joslin</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Shoff</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Successful treatment of chronic stromal acanthamoeba keratitis with oral voriconazole monotherapy.</article-title>
            <source>Cornea</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>29</volume>
            <issue>9</issue>
            <fpage>1066</fpage>
            <page-range>1066-8</page-range>
            <pub-id pub-id-type="pmid">20539217</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sunada</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kimura</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nishi</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Toyokawa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ueda</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sakata</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Suzuki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Inoue</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ohashi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Asari</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Iwatani</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>In vitro evaluations of topical agents to treat Acanthamoeba keratitis.</article-title>
            <source>Ophthalmology</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>121</volume>
            <issue>10</issue>
            <fpage>2059</fpage>
            <page-range>2059-65</page-range>
            <pub-id pub-id-type="pmid">24880905</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kl&#x000fc;ppel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Reinhard</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sundmacher</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Daicker</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>[Therapy of advanced amoeba keratitis with keratoplasty &#x000e0; chaud and adjuvant cryotherapy].</article-title>
            <source>Ophthalmologe</source>
            <year>1997</year>
            <month>Feb</month>
            <volume>94</volume>
            <issue>2</issue>
            <fpage>99</fpage>
            <page-range>99-103</page-range>
            <pub-id pub-id-type="pmid">9156647</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seitz</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Resch</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Schl&#x000f6;tzer-Schrehardt</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Hofmann-Rummelt</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sauer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kruse</surname>
                <given-names>FE</given-names>
              </name>
            </person-group>
            <article-title>Histopathology and ultrastructure of human corneas after amniotic membrane transplantation.</article-title>
            <source>Arch Ophthalmol</source>
            <year>2006</year>
            <month>Oct</month>
            <volume>124</volume>
            <issue>10</issue>
            <fpage>1487</fpage>
            <page-range>1487-90</page-range>
            <pub-id pub-id-type="pmid">17030720</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Szentm&#x000e1;ry</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Goebels</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bischoff</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Seitz</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>[Photodynamic therapy for infectious keratitis].</article-title>
            <source>Ophthalmologe</source>
            <year>2012</year>
            <month>Feb</month>
            <volume>109</volume>
            <issue>2</issue>
            <fpage>165</fpage>
            <page-range>165-70</page-range>
            <pub-id pub-id-type="pmid">22350551</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Krysik</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Wroblewska-Czajka</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lyssek-Boron</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wylegala</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Dobrowolski</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Total Penetrating Keratoplasty: Indications, Therapeutic Approach, and Long-Term Follow-Up.</article-title>
            <source>J Ophthalmol</source>
            <year>2018</year>
            <volume>2018</volume>
            <fpage>9580292</fpage>
            <pub-id pub-id-type="pmid">29850220</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kandori</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Inoue</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Shimabukuro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hayashi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hori</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Maeda</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tano</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Four cases of Acanthamoeba keratitis treated with phototherapeutic keratectomy.</article-title>
            <source>Cornea</source>
            <year>2010</year>
            <month>Oct</month>
            <volume>29</volume>
            <issue>10</issue>
            <fpage>1199</fpage>
            <page-range>1199-202</page-range>
            <pub-id pub-id-type="pmid">20595894</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khan</surname>
                <given-names>YA</given-names>
              </name>
              <name>
                <surname>Kashiwabuchi</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Martins</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Castro-Combs</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Kalyani</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Stanley</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Flikier</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Behrens</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis: report of 3 cases.</article-title>
            <source>Ophthalmology</source>
            <year>2011</year>
            <month>Feb</month>
            <volume>118</volume>
            <issue>2</issue>
            <fpage>324</fpage>
            <page-range>324-31</page-range>
            <pub-id pub-id-type="pmid">20884060</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anwar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Siddiqui</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Raza Shah</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>NA</given-names>
              </name>
            </person-group>
            <article-title>Antidiabetic Drugs and Their Nanoconjugates Repurposed as Novel Antimicrobial Agents against Acanthamoeba <italic>castellanii</italic>.</article-title>
            <source>J Microbiol Biotechnol</source>
            <year>2019</year>
            <month>May</month>
            <day>28</day>
            <volume>29</volume>
            <issue>5</issue>
            <fpage>713</fpage>
            <page-range>713-720</page-range>
            <pub-id pub-id-type="pmid">31030451</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gomart</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Denis</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bourcier</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Dory</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Abou-Bacar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Candolfi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sauer</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>In Vitro Amoebicidal Activity of Titanium Dioxide/UV-A Combination Against Acanthamoeba.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2018</year>
            <month>Sep</month>
            <day>04</day>
            <volume>59</volume>
            <issue>11</issue>
            <fpage>4567</fpage>
            <page-range>4567-4571</page-range>
            <pub-id pub-id-type="pmid">30242357</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Daas</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Szentm&#x000e1;ry</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Eppig</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Langenbucher</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hasenfus</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Roth</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Saeger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>N&#x000f6;lle</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lippmann</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>B&#x000f6;hringer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Reinhard</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kelbsch</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Messmer</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pleyer</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Roters</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zhivov</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Engelmann</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Schrecker</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zumhagen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Thieme</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Darawsha</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Meyer-Ter-Vehn</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Dick</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>G&#x000f6;rsch</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Hermel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kohlhaas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Seitz</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>[The German Acanthamoeba keratitis register: Initial results of a multicenter study].</article-title>
            <source>Ophthalmologe</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>112</volume>
            <issue>9</issue>
            <fpage>752</fpage>
            <page-range>752-63</page-range>
            <pub-id pub-id-type="pmid">25833754</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mascarenhas</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lalitha</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Prajna</surname>
                <given-names>NV</given-names>
              </name>
              <name>
                <surname>Srinivasan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>D'Silva</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Oldenburg</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Borkar</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Esterberg</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Lietman</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Keenan</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Acanthamoeba, fungal, and bacterial keratitis: a comparison of risk factors and clinical features.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>157</volume>
            <issue>1</issue>
            <fpage>56</fpage>
            <page-range>56-62</page-range>
            <pub-id pub-id-type="pmid">24200232</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Raghavan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Baidwal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vijayaraghavan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rajeswari</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rajaraman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Venkatapathy</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Menon</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rammohan</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic Evaluation of Co-Occurrence of Acanthamoeba and Fungi in Keratitis: A Preliminary Report.</article-title>
            <source>Cornea</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>37</volume>
            <issue>2</issue>
            <fpage>227</fpage>
            <page-range>227-234</page-range>
            <pub-id pub-id-type="pmid">29111995</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bacon</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Dart</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Ficker</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Matheson</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Wright</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Acanthamoeba keratitis. The value of early diagnosis.</article-title>
            <source>Ophthalmology</source>
            <year>1993</year>
            <month>Aug</month>
            <volume>100</volume>
            <issue>8</issue>
            <fpage>1238</fpage>
            <page-range>1238-43</page-range>
            <pub-id pub-id-type="pmid">8341508</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Varacalli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Di Zazzo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mori</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Dohlman</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Spelta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Coassin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bonini</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Challenges in Acanthamoeba Keratitis: A Review.</article-title>
            <source>J Clin Med</source>
            <year>2021</year>
            <month>Mar</month>
            <day>01</day>
            <volume>10</volume>
            <issue>5</issue>
            <pub-id pub-id-type="pmid">33804353</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81120.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carnt</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Stapleton</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Strategies for the prevention of contact lens-related Acanthamoeba keratitis: a review.</article-title>
            <source>Ophthalmic Physiol Opt</source>
            <year>2016</year>
            <month>Mar</month>
            <volume>36</volume>
            <issue>2</issue>
            <fpage>77</fpage>
            <page-range>77-92</page-range>
            <pub-id pub-id-type="pmid">26691018</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
